Talsaclidine
- Generic Name
- Talsaclidine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H15NO
- CAS Number
- 147025-53-4
- Unique Ingredient Identifier
- 1O8VSL798T
- Background
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT02264093
Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 36
- Registration Number
- NCT02264067
Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2014-09-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 54
- Registration Number
- NCT02249351
Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 198
- Registration Number
- NCT02248116
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath